Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Na, Yoo Jin | - |
dc.contributor.author | Lee, Dae-Hee | - |
dc.contributor.author | Kim, Jung Lim | - |
dc.contributor.author | Kim, Bo Ram | - |
dc.contributor.author | Park, Seong Hye | - |
dc.contributor.author | Jo, Min Jee | - |
dc.contributor.author | Jeong, Soyeon | - |
dc.contributor.author | Kim, Hong Jun | - |
dc.contributor.author | Lee, Suk-Young | - |
dc.contributor.author | Jeong, Yoon A. | - |
dc.contributor.author | Oh, Sang Cheul | - |
dc.date.accessioned | 2021-09-03T03:17:33Z | - |
dc.date.available | 2021-09-03T03:17:33Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-08 | - |
dc.identifier.issn | 1357-2725 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/82628 | - |
dc.description.abstract | Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is one of the most effective cancer treatments owing to its ability to selectively kill cancer cells, without affecting normal cells. However, it has been reported that several gastric cancer cells show resistance to TRAIL because of a scarcity of death receptor 5 (DR5) expressed on the cell surface. In this study, we show that cyclopamine sensitizes gastric cancer cells to TRAIL induced apoptosis by elevating the expression of DR5. Interestingly, survivin hampers the existence of DR5 protein under normal conditions and cyclopamine decreases the expression of survivin, thus acting as a TRAIL sensitizer. Mechanistically, cyclopamine induces endoplasmic reticulum (ER) stress via reactive oxygen species (ROS) and CHOP, the last protein of the ER stress pathway and it regulates the proteasome degradation of survivin. Taken together, our results indicate that cyclopamine can be used for combination therapy in TRAIL resistant gastric cancer cells. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | HUMAN ESOPHAGEAL CANCER | - |
dc.subject | UP-REGULATION | - |
dc.subject | GLIOMA-CELLS | - |
dc.subject | INHIBITION | - |
dc.subject | PATHWAY | - |
dc.subject | INDUCTION | - |
dc.subject | DR5 | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | ACTIVATION | - |
dc.subject | EXPRESSION | - |
dc.title | Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Bo Ram | - |
dc.contributor.affiliatedAuthor | Oh, Sang Cheul | - |
dc.identifier.doi | 10.1016/j.biocel.2017.06.010 | - |
dc.identifier.scopusid | 2-s2.0-85020850489 | - |
dc.identifier.wosid | 000407523000016 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, v.89, pp.147 - 156 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | - |
dc.citation.volume | 89 | - |
dc.citation.startPage | 147 | - |
dc.citation.endPage | 156 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | HUMAN ESOPHAGEAL CANCER | - |
dc.subject.keywordPlus | UP-REGULATION | - |
dc.subject.keywordPlus | GLIOMA-CELLS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | INDUCTION | - |
dc.subject.keywordPlus | DR5 | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordAuthor | TRAIL-resistance | - |
dc.subject.keywordAuthor | Cyclopamine | - |
dc.subject.keywordAuthor | CHOP | - |
dc.subject.keywordAuthor | Survivin | - |
dc.subject.keywordAuthor | Death receptor 5 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.